Cosmos Study October 14, 2025 Dual-Team Study Team A:Kersten Bartelt, RNEric Barkley Team B:Joel Jones, PharmDJoe Deckert, PhD Key Findings Among non-diabetic patients without chronic kidney disease (CKD), there was a minimal increase of 0.01 mg/dL to 0.02 mg/dL in serum creatinine in the months following initiation of semaglutide, liraglutide, or tirzepatide
This is important as hypoglycemia can be dangerous and lead to complications
A genetic consultation using the Precision Peptide Genetic Test ($99 add-on after your first month) reveals how variants in GLP1R, GIPR, FTO, and MC4R pathways influence your personal weight loss trajectory, enabling truly precision-guided therapy
January 25, 2024Devaraj Ediga Visited dr juvita aesthetics
Now, imagine those impacts applied to the American population, almost 100 times greater than the Canadian population and more likely to consume more of those foods today
Read more Research & Evidence Complete analysis of key studies including the 2014 retraction, LIFT-AD failure, and independent supporting data
